The University of Colorado Boulder signs option agreement with Nanoly Bioscience for vaccine protection technology.
Life sciences startup Nanoly Bioscience has entered into an option agreement with the University of Colorado Boulder to develop a technique for delivering vaccines to rural and underdeveloped areas of the world. Vaccines used to treat conditions such as measles, tetanus, polio and others have to be kept cool during transportation and storage – around…
The rest of this content is only accessible to Global Venturing Subscribers.
This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.
